http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012224592-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc19c95b0df7036cfb5c5a0afbeb8f79 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152 |
| filingDate | 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f494b55249201500bdf83ae1e1ea0c21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c100d2fa90fd95275cead9b40363824 |
| publicationDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012224592-A |
| titleOfInvention | Antitumor drugs for neuroblastoma |
| abstract | 【Task】 The present invention provides an antitumor agent having an excellent antitumor action against neuroblastoma. [Solution] General formula (1): (In the formula, R 1 represents a phenyl group. R 2 represents an alkyl group having 1 to 5 carbon atoms; a phenyl group optionally substituted with a nitro group as a substituent; or an optionally substituted benzoyl group. Represents an amino group, and R 3 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. The present invention relates to an antitumor agent for neuroblastoma comprising a pyrazolone compound represented by the formula (I) or a salt thereof as an active ingredient, particularly an antitumor agent for neuroblastoma in the pediatric region. [Selection figure] None |
| priorityDate | 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.